Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
NuGen Medical Devices Inc ( (TSE:NGMD) ) has issued an announcement.
NuGen Medical Devices Inc. has temporarily halted sales of its devices in Canada after its Health Canada licence expired due to an untimely certificate renewal, a lapse the company stresses is administrative rather than related to safety or regulatory enforcement. NuGen has already submitted a new licence application and is in active dialogue with Health Canada, expecting Canadian sales to resume once the licence is renewed, while its operations and product availability in other international markets remain unaffected.
More about NuGen Medical Devices Inc
NuGen Medical Devices Inc. is a medical technology company that develops next-generation needle-free devices for subcutaneous drug delivery. Its flagship InsuJet system, approved in 42 countries, targets the global diabetes market by offering an alternative to traditional needle-based insulin administration.
Average Trading Volume: 73,518
Technical Sentiment Signal: Sell
Current Market Cap: C$7.32M
See more data about NGMD stock on TipRanks’ Stock Analysis page.